Daniel Katzman

Mr. Katzman has over twenty years of experience in the life sciences industry. Before founding NeuroHealing he served as VP of Business Development at Oridion Medical Ltd, a publicly traded company (Zurich SWX: ORIDN). By leading one of Oridion’s two divisions, Mr. Katzman supervised clinical trials, regulatory approval, intellectual property and marketing. Additionally, he has been granted four US patents, has led a pivotal, multi-center Phase III study and has obtained FDA approval for a drug-device combination product which included an NDA and a 510(k). Mr. Katzman received his graduate degree in Biochemistry from Universidad Nacional de La Plata, Argentina.